ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)
$10.68 0.28 (2.6923%)
Analysed ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) News Sources
Is GeneDx (WGS) Using Sponsored NPC Testing to Quietly Strengthen Its Data Advantage?
24-03-2026
yahoo.com
Zevra Ties NPC Testing Push To Valuation Gap And New CFO
23-03-2026
yahoo.com
Zevra Therapeutics Reports Inducement Grant to New Chief Financial Officer Under Nasdaq Listing Rule 5635(c)(4)
20-03-2026
yahoo.com
GeneDx (WGS), Zevra Therapeutics (ZVRA) Partner to Launch Sponsored Genetic Testing Program for NPC
20-03-2026
yahoo.com
Zevra Therapeutics Sells SDX Portfolio to Commave Therapeutics for $50 Million
16-03-2026
yahoo.com
Zevra Therapeutics Inc (ZVRA) Q4 2025 Earnings Call Highlights: Strong Revenue Growth Driven by ...
12-03-2026
yahoo.com
Is Zevra Therapeutics (ZVRA) Pricing Reflecting Its Strong Multi‑Year Share Price Performance
11-03-2026
yahoo.com
WGS, Zevra Partner to Launch Genetic Testing for Niemann-Pick Type C
11-03-2026
yahoo.com
Can Zevra Therapeutics (ZVRA) Turn NPC Genetic Testing Access Into a Durable Rare-Disease Edge?
11-03-2026
yahoo.com
Why Zevra Therapeutics Stock Zoomed 21% Higher Today
10-03-2026
fool.com
What is the current price of ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)?
The current price of ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) is $10.68.
ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) absolute price change since previous trading day?
The absolute price change of ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) since the previous trading day is $0.28.
ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) percentage price change since previous trading day?
The percentage price change of ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) since the previous trading day is 2.6923%.
What is the most recent average sentiment score for ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)?
The most recent average sentiment score for ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) is 90 out of 100.
What is the most recent average sentiment for ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)?
The most recent sentiment for ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ) is .
SEC-8K** Filing Available For ZEVRA THERAPEUTICS INC (ZVRA:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.